Genetics & Environmental Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics & Environmental Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antibody Libraries
Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems
November 22nd, 2007
Dyax Corp. (NASDAQ: DYAX) announced the extension of the antibody library collaboration with ImClone Systems Incorporated (NASDAQ: IMCL) for the discovery of therapeutic antibodies. Under the terms of this agreement, ImClone will continue to have access to Dyax's proprietary phage display technology for an additional four years. To date, ImClone has successfully advanced into Phase 2 clinical trials three fully human monoclonal antibodies against EGFR, IGF-1R and KDR that were identified using Dyax's proprietary technology. Under the extended agreement, Dyax will continue to receive annual license fees from ImClone, as well as clinical milestone payments and royalties...
Source: Genetics & Environmental Business Week (2007-11-22)
|
